Stockreport

FDA signs off on registration study of Capricor's DMD candidate CAP-1002; shares up 34% premarket [Seeking Alpha]

Capricor Therapeutics, Inc.  (CAPR) 
Last capricor therapeutics, inc. earnings: 3/18 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: capricor.com/investors
PDF FDA signs off on registration study of Capricor's DMD candidate CAP-1002; shares up 34% premarketNano cap Capricor Therapeutics (NASDAQ:CAPR) is up34% premarket on modes [Read more]